The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dose-escalation of the first-in human phase I/Ib study of ABTL0812, a novel antitumor drug inhibiting the Akt/mTOR pathway in patients with advanced solid tumors.
 
Laura Vidal Boixader
Consulting or Advisory Role - Ability Pharma (Inst)
Research Funding - Ability Pharma (Inst)
 
Lydia Gaba
No Relationships to Disclose
 
Iván Victoria
No Relationships to Disclose
 
Merce Brunet
No Relationships to Disclose
 
Pilar Paredes
No Relationships to Disclose
 
Elvira Buxo
No Relationships to Disclose
 
Teresa Vilella
No Relationships to Disclose
 
Gisela Riu
No Relationships to Disclose
 
Marc Cortal
Employment - Ability Pharma
Honoraria - Ability Pharma
 
Mariana Gomez-Ferreria
Employment - Ability Pharma
Honoraria - Ability Pharma
 
Jose Alfon
Employment - Ability Pharma
Stock and Other Ownership Interests - Ability Pharma
Honoraria - Ability Pharma
 
Carles Domenech
Employment - Ability Pharma
Leadership - Ability Pharma
Stock and Other Ownership Interests - Ability Pharma
Honoraria - Ability Pharma
 
Pedro Gascon
Consulting or Advisory Role - Ability Pharma (Inst)
Research Funding - Ability Pharma (Inst)